No Data
No Data
No Data
No Data
No Data
Investors Don't See Light At End Of Changchun High-Tech Industry (Group) Co., Ltd.'s (SZSE:000661) Tunnel
With a price-to-earnings (or "P/E") ratio of 10x Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) may be sending very bullish signals at the moment, given that almost half of all companies
Simply Wall StMay 2 22:27 ET
Changchun Hi-Tech (000661.SZ) subsidiary's application for marketing licensing of Baike Bio's live attenuated nasal spray influenza vaccine was accepted
Changchun Hi-Tech (000661.SZ) issued an announcement. The company's subsidiary Changchun Baike Biotechnology Co., Ltd. (abbreviated as “...
Zhitong FinanceApr 23 07:15 ET
Changchun Hi-Tech (000661.SZ): Net profit of 859 million yuan in the first quarter increased 0.20% year-on-year
Gelonghui, April 19 | Changchun Hi-Tech (000661.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 3.177 billion yuan, up 14.39% year on year; net profit attributable to shareholders of listed companies was 859 million yuan, up 0.20% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 847 million yuan, down 0.86% year on year; basic earnings per share were 2.13 yuan.
Gelonghui FinanceApr 19 04:24 ET
Changchun Hi-Tech (000661.SZ): Application for marketing of injectable triprorelin acetate microspheres accepted
Gelonghui, April 18 | Changchun Hi-Tech (000661.SZ) announced, Changchun Hi-Tech (000661.SZ) announced that the subsidiary Changchun Jinsai Pharmaceutical Co., Ltd. received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's marketing application for injectable triprorelin acetate microspheres was accepted. The company's injectable triprorelin acetate microsphere products improve drug safety by improving drug release characteristics, optimizing prescriptions and processes, and making it possible for pediatric patients to administer fixed doses. A more convenient method of administration supported by evidence-based medical evidence will be central precocious puberty (C
Gelonghui FinanceApr 18 08:15 ET
Declining Stock and Solid Fundamentals: Is The Market Wrong About Changchun High-Tech Industries (Group) Inc. (SZSE:000661)?
Changchun High-Tech Industries (Group) (SZSE:000661) has had a rough month with its share price down 9.8%. However, stock prices are usually driven by a company's financial performance over the long
Simply Wall StApr 11 22:00 ET
Changchun Hi-Tech (000661.SZ) plans to pay 45 yuan for 10 shares to be deducted from interest on April 18
Changchun Hi-Tech (000661.SZ) announced that the company's 2023 equity distribution plan: 45 yuan for every 10 shares...
Zhitong FinanceApr 11 08:53 ET
No Data
No Data